Items where authors include "Irvine, J"

Article

Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736

Abani, O, Abbas, A, Abbas, F et al. (4809 more authors) (2021) Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. The Lancet, 397 (10289). pp. 2049-2059. ISSN 0140-6736

Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736

Jukes, CA, Ijaz, UZ, Buckley, A orcid.org/0000-0002-2790-0717 et al. (6 more authors) (2020) Bile salt metabolism is not the only factor contributing to Clostridioides (Clostridium) difficile disease severity in the murine model of disease. Gut Microbes, 11 (3). pp. 481-496. ISSN 1949-0976

Dennis, M, Mead, G, Forbes, J et al. (1294 more authors) (2019) Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial. The Lancet, 393 (10168). pp. 265-274. ISSN 0140-6736

Spencer, J, Leuzzi, R, Buckley, A orcid.org/0000-0002-2790-0717 et al. (4 more authors) (2014) Vaccination against Clostridium difficile using toxin fragments: Observations and analysis in animal models. Gut microbes, 5 (2). pp. 225-232. ISSN 1949-0976